How have GRAY shares performed in 2024?

Graybug Vision's stock was trading at $2.86 at the beginning of 2024. Since then, GRAY stock has increased by 51.7% and is now trading at $4.3399. View the best growth stocks for 2024 here .

How were Graybug Vision's earnings last quarter?

Graybug Vision, Inc. (NASDAQ:GRAY) released its earnings results on Thursday, November, 11th. The company reported ($5.32) EPS for the quarter, missing the consensus estimate of ($5.18) by $0.14.

When did Graybug Vision's stock split?

Graybug Vision's stock reverse split before market open on Monday, March 20th 2023. The 1-14 reverse split was announced on Monday, March 20th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, March 20th 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

When did Graybug Vision IPO?

Graybug Vision (GRAY) raised $75 million in an IPO on Friday, September 25th 2020. The company issued 4,700,000 shares at $15.00-$17.00 per share. SVB Leerink and Piper Sandler acted as the underwriters for the IPO and Needham & Co. and Wedbush PacGrow were co-managers.

How do I buy shares of Graybug Vision?

Shares of GRAY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:GRAY

Graybug Vision (GRAY) Stock Price, News & Analysis

→ A new way to collect income from stocks (From DTI) (Ad)

Free GRAY Stock Alerts

$4.34

-0.05 (-1.14%)

(As of 04/16/2024 ET)

Compare

Today's Range: $4.25
▼
$4.40
50-Day Range: $3.46
▼
$5.80
52-Week Range: $5.00
▼
$22.12

Volume: 5,366 shs
Average Volume: 2,165 shs
Market Capitalization: $6.82 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Competitors Financials Insider Trades SEC Filings Social Media

Get Graybug Vision alerts:

Ad Insiders Exposed

This consistently signaled gains of 453%... 610%... and even 1036%...

It doesn’t happen often, but occasionally, something completely unique comes across my radar. In this case, I’m talking about legal “Insider Trading”. Traders who have consistently signaled 453% … 610% .. and even 1036%... gains. And until now they have been doing it completely under the radar. In an upcoming interview I am revealing the strategy behind this gold-mine and how you can piggy back their every trade.

About Graybug Vision Stock (NASDAQ:GRAY)

Graybug Vision, Inc., a clinical-stage biopharmaceutical company, focuses on the development of medicines for the treatment of diseases of the retina and optic nerve. The company's lead product candidate is GB-102, an intravitreal injection of a microparticle depot formulation of sunitinib that is in Phase I/IIa and IIb clinical trials for the treatment of wet age-related macular degeneration, as well as in Phase IIa clinical trial to treat diabetic macular edema. It also develops GB-102, for the treatment of diabetic retinopathy; and GB-401, an intravitreally injected implant formulation of a beta-adrenergic receptor inhibitor to treat primary open-angle glaucoma. The company was formerly known as Graybug LLC and changed its name to Graybug Vision, Inc. in 2016. Graybug Vision, Inc. was incorporated in 2011 and is based in Redwood City, California.

GRAY Stock Price History

30 days | 90 days | 365 days | Advanced Chart

GRAY Stock News Headlines

January 4, 2024 | forbes.com

Best Vision Insurance Companies Of 2024

December 22, 2023 | 9to5mac.com

Bloomberg: Vision Pro production moving at full speed, February launch planned

April 17, 2024 | DTI (Ad)

Start loving Mondays like this

Wouldn’t you love to start looking forward to Mondays? We’re in a New Paradigm Shift in the market that could make it possible! You see, rallies over the weekends have become much more common in the last few years. Imagine hitting a few buttons on your phone or laptop to place a quick trade before the weekend hits… And coming back on Monday to what could be extra income sitting in your account… Weekend after weekend!

November 14, 2023 | usatoday.com

Best vision insurance companies of November 2023

August 3, 2023 | markets.businessinsider.com

Complement Therapeutics Appoints Dr Parisa Zamiri MD, as Chief Medical Officer

June 10, 2023 | appleinsider.com

Apple Vision Pro $3,499 mixed-reality headset launches at WWDC after years of rumors

March 28, 2023 | marketwatch.com

Ocular Drug Delivery Technology Market Outlook By 2031

March 22, 2023 | finanznachrichten.de

Graybug Vision, Inc. Announces Name and Trading Symbol Change

April 17, 2024 | DTI (Ad)

Start loving Mondays like this

March 21, 2023 | finanznachrichten.de

Graybug Vision, Inc.: Graybug Announces Name and Trading Symbol Change

March 21, 2023 | benzinga.com

Graybug Vision Stock (NASDAQ:GRAY), Dividends

March 20, 2023 | finance.yahoo.com

CalciMedica Announces Closing of Merger with Graybug Vision and Concurrent Private Placement

March 20, 2023 | finance.yahoo.com

Individual investors are Graybug Vision, Inc.'s (NASDAQ:GRAY) biggest owners and were hit after market cap dropped US$31m

March 20, 2023 | finance.yahoo.com

Graybug Announces Name and Trading Symbol Change

February 27, 2023 | marketwatch.com

Ocular Drug Delivery Technology Market is Booming Worldwide with Top Countries Data

February 14, 2023 | businesswire.com

GRAYBUG VISION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Graybug Vision, Inc. - GRAY

February 9, 2023 | finanznachrichten.de

DelveInsight Business Research, LLP: The Global Ocular Drug Delivery System Market to Register Growth at a CAGR of ~7% by 2027 | DelveInsight

February 9, 2023 | yahoo.com

The Global Ocular Drug Delivery System Market to Register Growth at a CAGR of ~7% by 2027 | DelveInsight

January 25, 2023 | seekingalpha.com

GRAY Graybug Vision, Inc.

December 6, 2022 | markets.businessinsider.com

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates IMGO, GRAY, APEN, SAL

December 5, 2022 | wsj.com

INVESTOR ALERT: The M&A Class Action Firm Announces the Investigation of Graybug Vision, Inc. - GRAY

November 24, 2022 | benzinga.com

GRAYBUG VISION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Graybug Vision, Inc. - GRAY

November 22, 2022 | marketwatch.com

GRAY STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Merger of Graybug Vision, Inc. Is Fair to Shareholders

November 22, 2022 | marketwatch.com

Graybug Vision Shares Fall Premarket on CalciMedica Tie-Up >GRAY

November 22, 2022 | benzinga.com

Shareholder Alert: Ademi LLP investigates whether Graybug Vision, Inc. has entered into a Fair Transaction with CalciMedica

November 22, 2022 | finance.yahoo.com

Graybug Vision Agrees To Merge With Inflammatory Disease-Focused Biopharma

November 22, 2022 | finanznachrichten.de

Graybug Vision, Inc.; CalciMedica Inc.: Graybug and CalciMedica Enter into Definitive Merger Agreement

See More Headlines

Receive GRAY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Graybug Vision and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/11/2021
Today: 4/17/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Current Symbol: NASDAQ:GRAY
CUSIP: N/A
CIK: 1534133
Web: www.graybug.com
Phone: N/A
Fax: N/A
Employees: 27
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($24.23)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-35,600,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -77.61%
Return on Assets: -71.34%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 10.73
Quick Ratio: 10.72

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $1.67 per share
Price / Book: 2.60

Miscellaneous

Outstanding Shares: 1,571,000
Free Float: 20,250,000
Market Cap: $6.82 million
Optionable: Not Optionable
Beta: 1.20

10 "Recession Proof" Stocks That Will Thrive in Any Market

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

Dr. Frederic Guerard Pharm.D. (Age 49)
Pres, CEO, Sec. & Director
Comp: $931.02k
Mr. Robert S. Breuil (Age 60)
CFO & Treasurer
Comp: $577.47k
Dr. Gerald D. Cagle Ph.D. (Age 78)
Sr. Advisor & Head of Bus. Devel.
Comp: $44.67k
Dr. Parisa Zamiri M.D. (Age 57)
Ph.D., Chief Medical Officer
Comp: $662.11k
Dr. Peter A. Campochiaro M.D.
Co-Founder
Dr. Peter J. McDonnell M.D. (Age 63)
Co-Founder
Ms. Bettina Maunz
Chief People Officer & Head of Communications
Mr. Ming Yang
Sr. VP of R&D
Dr. Ward M. Peterson Ph.D.
Sr. VP of Preclinical Devel.
Mr. Ali Kakavand Ph.D.
VP & Head of Program Management

Key Competitors

View All Competitors

GRAY Stock Analysis - Frequently Asked Questions

How have GRAY shares performed in 2024?: Graybug Vision's stock was trading at $2.86 at the beginning of 2024. Since then, GRAY stock has increased by 51.7% and is now trading at $4.3399.
View the best growth stocks for 2024 here.
How were Graybug Vision's earnings last quarter?: Graybug Vision, Inc. (NASDAQ:GRAY) released its earnings results on Thursday, November, 11th. The company reported ($5.32) EPS for the quarter, missing the consensus estimate of ($5.18) by $0.14.
When did Graybug Vision's stock split?: Graybug Vision's stock reverse split before market open on Monday, March 20th 2023. The 1-14 reverse split was announced on Monday, March 20th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, March 20th 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

When did Graybug Vision IPO?: Graybug Vision (GRAY) raised $75 million in an IPO on Friday, September 25th 2020. The company issued 4,700,000 shares at $15.00-$17.00 per share. SVB Leerink and Piper Sandler acted as the underwriters for the IPO and Needham & Co. and Wedbush PacGrow were co-managers.
How do I buy shares of Graybug Vision?: Shares of GRAY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:GRAY) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Graybug Vision (GRAY) Stock Price, News & Analysis

About Graybug Vision Stock (NASDAQ:GRAY)

GRAY Stock Price History

GRAY Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

GRAY Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info